Immunicum Announces Encouraging Signs of Survival Benefit in Phase II MERECA Trial of Ilixadencel in Kidney Cancer

    NEXT STORY
    SpringWorks Therapeutics to Present at Upcoming Investor Conferences
    PREV STORY
    Valneva initie une étude sur l’homogénéité des lots cliniques de Phase 3 de son candidat vaccin à injection unique contre le chikungunya
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Meharry Medical College, Morehouse School of Medicine Partner with University of Zambia to Enhance Global Health Education and Research

    author_avatar
    NASDAQ Market News

    AzurRx BioPharma CEO Issues Letter to Shareholders

    author_avatar
    NASDAQ Market News

    Relievant Medsystems Announces First Patient Enrollment in the INTRACEPT Clinical Study

    SUNNYVALE, Calif., Oct. 24, 2017 (GLOBE NEWSWIRE) -- Relievant Medsystems, a privately held medical ...

    author_avatar
    NASDAQ Market News